BlackRock Investment Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.77M Sell
207,075
-654
-0.3% -$5.6K ﹤0.01% 2297
2016
Q3
$1.71M Buy
207,729
+135
+0.1% +$1.13K ﹤0.01% 2281
2016
Q2
$1.67M Buy
207,594
+15,774
+8% +$126K ﹤0.01% 2254
2016
Q1
$1.29M Buy
191,820
+3,564
+2% +$23.5K ﹤0.01% 2315
2015
Q4
$1.48M Buy
188,256
+1,387
+0.7% +$10.2K ﹤0.01% 2295
2015
Q3
$1.07M Buy
186,869
+3,108
+2% +$19.2K ﹤0.01% 2555
2015
Q2
$994K Buy
183,761
+176,857
+2,562% +$912K ﹤0.01% 2756
2015
Q1
$32K Buy
6,904
+211
+3% +$917 ﹤0.01% 3363
2014
Q4
$28K Hold
6,693
﹤0.01% 3401
2014
Q3
$35K Buy
6,693
+1,147
+21% +$5.89K ﹤0.01% 3334
2014
Q2
$18K Sell
5,546
-87,570
-94% -$291K ﹤0.01% 3439
2014
Q1
$323K Buy
93,116
+947
+1% +$3.55K ﹤0.01% 3139
2013
Q4
$334K Buy
92,169
+288
+0.3% +$1K ﹤0.01% 3128
2013
Q3
$276K Buy
91,881
+11,085
+14% +$31.2K ﹤0.01% 3131
2013
Q2
$322K Buy
+80,796
New +$308K ﹤0.01% 3064

Other funds holding NEO

BlackRock Investment Management's NEO Position: Q4 2016 in Review

BlackRock Investment Management reduced its NeoGenomics (NEO) stake by 0.31% in Q4 2016, selling an estimated $5.6K and leaving 207,075 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2297.

BlackRock Investment Management first reported a position in NEO in Q2 2013 and has held it in 15 quarters since. 143 funds tracked by Wall St. Rank hold NEO as of Q4 2016.

  • BlackRock Investment Management held 207,075 shares of NeoGenomics worth $1.77M as of Q4 2016.
  • BlackRock Investment Management sold 654 NeoGenomics shares in Q4 2016, an estimated $5.6K.
  • NeoGenomics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2297 holding.
  • BlackRock Investment Management first reported a position in NeoGenomics in Q2 2013 and has held it in 15 quarters since.
  • 143 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.